Biography

Dr. Rajiv Kumar Jha is a renowned Nepalese surgeon and researcher, dedicated to advancing surgical techniques, integrating traditional medicine with modern healthcare, and fostering international collaboration in the medical field.

Dr. Rajiv Kumar Jha is a highly respected medical professional from Nepal, born on November 11, 1979, who has established himself as a distinguished surgeon, academic, and researcher with a broad international presence. Fluent in English, Chinese, and Nepali, he has skillfully navigated global healthcare landscapes, facilitating cross-cultural medical exchanges and advancing the integration of traditional and modern medicine. Based in China, Dr. Jha has taken on several pivotal roles in both academic and medical fields, including professorships and directorships, where he has worked to foster meaningful collaborations between Nepal and China. His leadership in these positions has significantly contributed to the development of medical research, particularly in the areas of surgical techniques and cancer therapies. Dr. Jha's academic and professional journey reflects his unwavering commitment to bridging cultural and scientific knowledge, and his dedication to medical advancement has earned him recognition both in Asia and worldwide. In addition to his research and teaching roles, Dr. Jha remains an active figure in the global medical community, working on initiatives that integrate traditional medical practices from Nepal and China with modern scientific approaches.

Dr. Jha’s research primarily focuses on the integration of traditional Chinese and Nepalese medicine with modern science to explore innovative treatments, particularly in the field of pancreatic cancer.

Dr. Rajiv Kumar Jha is renowned for his groundbreaking research on the role of traditional Chinese and Nepalese medicine in regulating mechanisms of pancreatic cancer. His work seeks to merge ancient medical knowledge with cutting-edge scientific techniques to uncover new treatments for complex diseases. Dr. Jha’s research interests are also aligned with improving surgical outcomes and exploring the potential of natural compounds in medical therapies. His ability to bridge diverse medical practices has positioned him as a leader in both traditional and modern medical research.

In medicine and research,

collaboration is the bridge between tradition and innovation.

Dr. Jha has authored over 20 peer-reviewed articles in internationally recognized journals, focusing on cancer treatments and the integration of traditional and modern medicine.

Dr. Jha’s scholarly work has been widely recognized, with over 20 peer-reviewed publications in prominent international journals. His research articles cover a wide range of topics, including the synergistic treatment of various cancers through nanotechnology, as well as the protective effects of natural compounds like resveratrol in severe pancreatitis. Notable publications include “Dual loading of nanoparticles with doxorubicin and icotinib for the synergistic suppression of non-small cell lung cancer” (International Journal of Medical Sciences, 2020) and “Docetaxel and doxorubicin codelivery by nanocarriers for synergistic treatment of prostate cancer” (Frontiers in Pharmacology, 2019). His work continues to have a profound impact on both the scientific and medical communities.